Every life saved begins with early detection. MPREG® empowers timely intervention—because no baby should be lost to preeclampsia. ...

MirZyme announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health...

The MirZyme Therapeutics team are delighted to announce that we have been granted a new US patent to predict and prevent pregnancy...

“Talent is rare but rarer is grit”. We are proud to share with you the news that our founder and CEO Professor Asif Ahmed PhD FRSB...

Professor Asif Ahmed is deeply honoured and humbled to receive this award from Maternal Aids Association for our groundbreaking work in...

We’re thrilled to announce that Professor Asif Ahmed, our founder and Executive Chairman, has been awarded the ‘Health Innovation &...

MirZyme, a leading UK-based FemTech dedicated to addressing pregnancy complications, proudly announces the appointment of Lord Oxmantown...

Team MirZyme have won the Lee Kuan Yew Global Business Plan Completion prize entitled: 'Best Professor-Student Team’, having been invited...

Geneva, April 2023. The partnership between Concept Foundation and MirZyme is a critical step toward in the prevention and treatment of...

MIRZYME THERAPEUTICS AWARDED THE FIRST FAST-TRACK INNOVATION PASSPORT FOR THE TREATMENT OF PREECLAMPSIA FROM THE MHRA, THE UK REGULATOR...

CEO of Mirzyme Professor Asif Ahmed (www.asifahmed.org) has been nominated for Birmingham Buisnessman Of The Year 2022. He is a...

Mirzyme has been selected as a finalist for the Women's Health Innovation Showcase USA. Out of 125 companies, Mirzyme is one of 24 to be...

The United Kingdom published its first policy commission report on maternal drug development. The report was launched in the House of...

The Nuffield Department of Women’s & Reproductive Health at the University of Oxford hosted an Academic-Industry Meeting Day (AIMday) in...

The UK government asked the views of organisations, experts and individuals to help inform the development of the government’s Women’s...

Birmingham, June 2021 A peer-reviewed article in the prestigious British Journal of Pharmacology “The Impact of COVID-19 on Pregnancy and...

The month of May is Preeclampsia Awareness Month. Through a series of webinars, discussions and workshops, MirZyme is raising awareness...

Preeclampsia is a life-threatening pregnancy disorder affecting one in twelve of 130 million annual pregnancies worldwide and causes the...

MirZyme Therapeutics partners with King Abdulaziz University to accelerate the development of targeted therapeutics using artificial...

PRESS RELEASE Scientists at MirZyme Therapeutics have discovered a cure for preeclampsia, a life- threatening hypertensive disorder...